Showing results (31-40 of 89) with videos related to
Sort By:
Pageof 9
Blood|August 9, 2011
Selective depletion of plasma prekallikrein or coagulation factor XII inhibits thrombosis in mice without increased risk of bleedingAlexey S Revenko, Dacao Gao, Jeff R Crosby, et al.Retrovirology|August 30, 2020
Interferon regulatory factor 4 as a therapeutic target in adult T-cell leukemia lymphomaDaniel A Rauch, Sydney L Olson, John C Harding, et al.Nucleic Acids Research|October 16, 2019
A novel and translational role for autophagy in antisense oligonucleotide trafficking and activityJoseph Ochaba, Andrew F Powers, Kaitlyn A Tremble, et al.Molecular Cancer Therapeutics|January 11, 2011
Transcription factor Stat5 knockdown enhances androgen receptor degradation and delays castration-resistant prostate cancer progression in vivoChristian Thomas, Amina Zoubeidi, Hidetoshi Kuruma, et al.Nucleic Acids Research|March 31, 2019
Differential uptake, kinetics and mechanisms of intracellular trafficking of next-generation antisense oligonucleotides across human cancer cell linesEmily Linnane, Paul Davey, Pei Zhang, et al.Haematologica|July 20, 2019
The contact system proteases play disparate roles in streptococcal sepsisJuliane Köhler, Claudia Maletzki, Dirk Koczan, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|July 16, 2019
Enhanced Potency of GalNAc-Conjugated Antisense Oligonucleotides in Hepatocellular Cancer ModelsYoungsoo Kim, Minji Jo, Joanna Schmidt, et al.Ebiomedicine|July 25, 2020
Kininogen supports inflammation and bacterial spreading during Streptococccus Pyogenes SepsisJuliane Köhler, Claudia Maletzki, Dirk Koczan, et al.Nature|August 4, 2012
Targeting nuclear RNA for in vivo correction of myotonic dystrophyThurman M Wheeler, Andrew J Leger, Sanjay K Pandey, et al.Cell Stem Cell|January 21, 2021
Selective antisense oligonucleotide inhibition of human IRF4 prevents malignant myeloma regeneration via cell cycle disruptionPhoebe K Mondala, Ashni A Vora, Tianyuan Zhou, et al.Pageof 9